Breast cancer pathology, receptor status, and patterns of metastasis in a rural appalachian population

Journal of Cancer Epidemiology

Volumn 2014, Issue , 2014, Pages

  Vona Davis, Linda ^a,b   Rose, David P ^b   Gadiyaram, Vijaya ^b   Ducatman, Barbara ^b   Hobbs, Gerald ^b   Hazard, Hannah ^a,b   Kurian, Sobha ^b   Abraham, Jame ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; RECEPTOR SUBTYPE;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; ARTICLE; BODY MASS; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; LATENT PERIOD; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; OBESITY; OVARY METASTASIS; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TRIPLE NEGATIVE BREAST CANCER; UNITED STATES; VISCERAL METASTASIS;

EID: 84893194347     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2014/170634     Document Type: Article

References (45)

1. Rose D. P., Vona-Davis L., Influence of obesity on breast cancer receptor status and prognosis. Expert Review of Anticancer Therapy 2009 9 8 1091 1101 2-s2.0-70350645290 10.1586/ERA.09.71
2. Mauri F. A., Maisonneuve P., Caffo O., Veronese S., Aldovini D., Ferrero S., Cozzaglio F., Palma P. D., Galligioni E., Barbareschi M., Prognostic value of estrogen receptor status can be improved by combined evaluation of p53, Bcl2 and PgR expression: an immunohistochemical study on breast carcinoma with long-term follow-up. International Journal of Oncology 1999 15 6 1137 1147 2-s2.0-0033450489
3. Bentzon N., Düring M., Rasmussen B. B., Mouridsen H., Kroman N., Prognostic effect of estrogen receptor status across age in primary breast cancer. International Journal of Cancer 2008 122 5 1089 1094 2-s2.0-38749117179 10.1002/ijc.22892 (Pubitemid 351214007)
4. Clark G. M., McGuire W. L., Hubay C. A., Pearson O. H., Marshall J. S., Progesterone receptors as a prognostic factor in stage II breast cancer. The New England Journal of Medicine 1983 309 22 1343 1347 2-s2.0-0021034680 (Pubitemid 14246555)
5. Bauer K. R., Brown M., Cress R. D., Parise C. A., Caggiano V., Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 2007 109 9 1721 1728 2-s2.0-34247569300 10.1002/cncr.22618 (Pubitemid 46668532)
6. Dent R., Trudeau M., Pritchard K. I., Hanna W. M., Kahn H. K., Sawka C. A., Lickley L. A., Rawlinson E., Sun P., Narod S. A., Triple-negative breast cancer: clinical features and patterns of recurrence. Clinical Cancer Research 2007 13 15 4429 4434 2-s2.0-34547661993 10.1158/1078-0432.CCR-06-3045 (Pubitemid 47219710)
7. Dolle J. M., Daling J. R., White E., Brinton L. A., Doody D. R., Porter P. L., Malone K. E., Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiology Biomarkers and Prevention 2009 18 4 1157 1166 2-s2.0-66649101370 10.1158/1055-9965.EPI-08-1005
8. Haffty B. G., Yang Q., Reiss M., Kearney T., Higgins S. A., Weidhaas J., Harris L., Hait W., Toppmeyer D., Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. Journal of Clinical Oncology 2006 24 36 5652 5657 2-s2.0-34247381115 10.1200/JCO.2006.06. 5664 (Pubitemid 46631305)
9. Dent R., Hanna W. M., Trudeau M., Rawlinson E., Sun P., Narod S. A., Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Research and Treatment 2009 115 2 423 428 2-s2.0-67349148556 10.1007/s10549-008-0086-2
10. Gordon N. H., Socioeconomic factors and breast cancer in black and white Americans. Cancer and Metastasis Reviews 2003 22 1 55 65 2-s2.0-0037344879 10.1023/A:1022212018158 (Pubitemid 36363514)
11. Krieger N., Chen J. T., Ware J. H., Kaddour A., Race/ethnicity and breast cancer estrogen receptor status: Impact of class, missing data, and modeling assumptions. Cancer Causes and Control 2008 19 10 1305 1318 2-s2.0-55849132652 10.1007/s10552-008-9202-1
12. Vona-Davis L., Rose D. P., The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. Journal of Women's Health 2009 18 6 883 893 2-s2.0-67650269851 10.1089/jwh.2008.1127
13. Vona-Davis L., Rose D. P., Hazard H., Howard-McNatt M., Adkins F., Partin J., Hobbs G., Triple-negative breast cancer and obesity in a rural appalachian population. Cancer Epidemiology Biomarkers and Prevention 2008 17 12 3319 3324 2-s2.0-57449087033 10.1158/1055-9965.EPI-08-0544
14. Coleman R. E., Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy? European Journal of Cancer 2009 45 11 1909 1915 2-s2.0-67649363481 10.1016/j.ejca.2009.04.022
15. Elder E. E., Kennedy C. W., Gluch L., Carmalt H. L., Janu N. C., Joseph M. G., Donellan M. J., Molland J. G., Gillett D. J., Patterns of breast cancer relapse. European Journal of Surgical Oncology 2006 32 9 922 927 2-s2.0-33750376050 10.1016/j.ejso.2006.06.001 (Pubitemid 44615591)
16. Imkampe A., Bendall S., Bates T., The significance of the site of recurrence to subsequent breast cancer survival. European Journal of Surgical Oncology 2007 33 4 420 423 2-s2.0-34247120526 10.1016/j.ejso.2006.09.005 (Pubitemid 46586085)
17. Pagani O., Price K. N., Gelber R. D., Castiglione-Gertsch M., Holmberg S. B., Lindtner J., Thürlimann B., Collins J., Fey M. F., Coates A. S., Goldhirsch A., Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. Breast Cancer Research and Treatment 2009 117 2 319 324 2-s2.0-68949122990 10.1007/s10549-008-0282-0
18. Drewnowski A., D. Rehm C., Solet D., Disparities in obesity rates: analysis by ZIP code area. Social Science and Medicine 2007 65 12 2458 2463 2-s2.0-35948992118 10.1016/j.socscimed.2007.07.001 (Pubitemid 350161055)
19. Trivers K. F., Lund M. J., Porter P. L., Liff J. M., Flagg E. W., Coates R. J., Eley J. W., The epidemiology of triple-negative breast cancer, including race. Cancer Causes and Control 2009 20 7 1071 1082 2-s2.0-68449087524 10.1007/s10552-009-9331-1
20. Dawood S., Broglio K., Gonzalez-Angulo A. M., Kau S.-W., Islam R., Hortobagyi G. N., Cristofanilli M., Prognostic value of body mass index in locally advanced breast cancer. Clinical Cancer Research 2008 14 6 1718 1725 2-s2.0-41549103014 10.1158/1078-0432.CCR-07-1479 (Pubitemid 351469456)
21. Proctor B. D., Dalaker J., Poverty in the United States: 2002. 2003 Washington, DC, USA US Government Printing Office
22. Ahluwalia I. B., Mack K. A., Murphy W., Mokdad A. H., Bales V. S., State-specific prevalence of selected chronic disease-related characteristics-behavioral risk factor surveillance system, 2001. MMWR Surveillance Summaries 2003 52 8 1 80 2-s2.0-0141975309
23. American Cancer Society, Cancer facts and figures. 2009, http://www.acs.org
24. Jubelirer S. J., Smith J. I., Gharib M., The changing pattern of early breast cancer and its primary management at CAMC. The West Virginia Medical Journal 1993 89 10 442 444 2-s2.0-0027671842
25. James J. J., Evans A. J., Pinder S. E., Gutteridge E., Cheung K. L., Chan S., Robertson J. F. R., Bone metastases from breast carcinoma: histopathological-radiological correlations and prognostic features. British Journal of Cancer 2003 89 4 660 665 2-s2.0-0043236248 10.1038/sj.bjc.6601198 (Pubitemid 37076169)
26. Hess K. R., Pusztai L., Buzdar A. U., Hortobagyi G. N., Estrogen receptors and distinct patterns of breast cancer relapse. Breast Cancer Research and Treatment 2003 78 1 105 118 2-s2.0-0037367214 10.1023/A:1022166517963 (Pubitemid 36223023)
27. Solomayer E.-F., Diel I. J., Meyberg G. C., Gollan C., Bastert G., Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Research and Treatment 2000 59 3 271 278 2-s2.0-0034097586 10.1023/A:1006308619659 (Pubitemid 30243049)
28. Kamby C., Andersen J., Ejlertsen B., Birkler N. E., Rytter L., Zedeler K., Thorpe S. M., Norgaard T., Rose C., Histological grade and steroid receptor content of primary brast cancer-impact on prognosis and possible modes of action. British Journal of Cancer 1988 58 4 480 486 2-s2.0-0023798488 (Pubitemid 18267804)
29. Rack B., Janni W., Gerber B., Strobl B., Schindlbeck C., Klanner E., Rammel G., Sommer H., Dimpfl T., Friese K., Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression? Breast Cancer Research and Treatment 2003 82 2 83 92 2-s2.0-10744227815 10.1023/B:BREA.0000003955.73738.9e (Pubitemid 37476008)
30. Carey L. A., Perou C. M., Livasy C. A., Dressler L. G., Cowan D., Conway K., Karaca G., Troester M. A., Chiu K. T., Edmiston S., Deming S. L., Geradts J., Cheang M. C. U., Nielsen T. O., Moorman P. G., Earp H. S., Millikan R. C., Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Journal of the American Medical Association 2006 295 21 2492 2502 2-s2.0-33744960226 10.1001/jama.295.21.2492 (Pubitemid 43854964)
31. Rakha E. A., El-Sayed M. E., Lee A. H. S., Elston C. W., Grainge M. J., Hodi Z., Blamey R. W., Ellis I. O., Prognostic significance of nottingham histologic grade in invasive breast carcinoma. Journal of Clinical Oncology 2008 26 19 3153 3158 2-s2.0-49249090695 10.1200/JCO.2007.15.5986
32. Urruticoechea A., Smith I. E., Dowsett M., Proliferation marker Ki-67 in early breast cancer. Journal of Clinical Oncology 2005 23 28 7212 7220 2-s2.0-27244443082 10.1200/JCO.2005.07.501
33. Chlebowski R. T., Chen Z., Anderson G. L., Rohan T., Aragaki A., Lane D., Dolan N. C., Paskett E. D., McTiernan A., Hubbell F. A., Adams-Campbell L. L., Prentice R., Ethnicity and breast cancer: factors influencing differences in incidence and outcome. Journal of the National Cancer Institute 2005 97 6 439 447 2-s2.0-20144372095 10.1093/jnci/dji064 (Pubitemid 40528607)
34. Dignam J. J., Wieand K., Johnson K. A., Fisher B., Xu L., Mamounas E. P., Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. Journal of the National Cancer Institute 2003 95 19 1467 1476 2-s2.0-0141651876 (Pubitemid 37279332)
35. Cleveland R. J., Eng S. M., Abrahamson P. E., Britton J. A., Teitelbaum S. L., Neugut A. I., Gammon M. D., Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiology Biomarkers and Prevention 2007 16 9 1803 1811 2-s2.0-34548819019 10.1158/1055-9965.EPI-06-0889 (Pubitemid 47450510)
36. Wynder E. L., Stellman S. D., The "over-exposed" control group. The American Journal of Epidemiology 1992 135 5 459 461 2-s2.0-0026525332
37. Mersin H., Yildirim E., Berberoglu U., Gülben K., The prognostic importance of triple negative breast carcinoma. Breast 2008 17 4 341 346 2-s2.0-48649108724 10.1016/j.breast.2007.11.031
38. Aleskandarany M. A., Rakha E. A., Ahmed M. A. H., Powe D. G., Paish E. C., MacMillan R. D., Ellis I. O., Green A. R., PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis. Breast Cancer Research and Treatment 2010 122 1 45 53 2-s2.0-77953545383 10.1007/s10549-009-0508-9
39. Demirkan B., Alacacioglu A., Yilmaz U., Relation of Body Mass Index (BMI) to Disease Free (DFS) and Distant Disease Free Survivals (DDFS) among Turkish women with operable breast carcinoma. Japanese Journal of Clinical Oncology 2007 37 4 256 265 2-s2.0-34547115728 10.1093/jjco/hym023 (Pubitemid 47096437)
40. de Mascarel I., Bonichon F., Durand M., Mauriac L., MacGrogan G., Soubeyran I., Picot V., Avril A., Coindre J. M., Trojani M., Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. European Journal of Cancer 1998 34 1 58 65 2-s2.0-0031938339 10.1016/S0959-8049(97)00344-4 (Pubitemid 28123381)
41. Colleoni M., Rotmensz N., Maisonneuve P., Sonzogni A., Pruneri G., Casadio C., Luini A., Veronesi P., Intra M., Galimberti V., Torrisi R., Andrighetto S., Ghisini R., Goldhirsch A., Viale G., Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Annals of Oncology 2007 18 10 1632 1640 2-s2.0-34547826147 10.1093/annonc/mdm268 (Pubitemid 47506249)
42. Vona-Davis L., Rose D. P., Angiogenesis, adipokines and breast cancer. Cytokine and Growth Factor Reviews 2009 20 3 193 201 2-s2.0-67349101253 10.1016/j.cytogfr.2009.05.007
43. Saxena N. K., Taliaferro-Smith L., Knight B. B., Merlin D., Anania F. A., O'Regan R. M., Sharma D., Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Research 2008 68 23 9712 9722 2-s2.0-57149100169 10.1158/0008-5472.CAN-08-1952
44. Liu C.-L., Chang Y.-C., Cheng S.-P., Chern S.-R., Yang T.-L., Lee J.-J., Guo I.-C., Chen C.-P., The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 2007 72 1-2 75 81 2-s2.0-37049024956 10.1159/000111097 (Pubitemid 350249133)
45. Ishikawa M., Kitayama J., Nagawa H., Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clinical Cancer Research 2004 10 13 4325 4331 2-s2.0-3042817487 10.1158/1078-0432.CCR-03-0749 (Pubitemid 38878870)